Clinical Trial Update: Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay

View source ↗

Summary

The AnchorDx UriFind bladder cancer validation trial (NCT05643690) is currently suspended during the urine sample collection phase.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: AnchorDx Medical Co. Ltd. US | Conditions: Bladder Cancer | Status: SUSPENDED